How has the combination of antibody-drug conjugate and checkpoint inhibitors revolutionized treatment for patients with metastatic urothelial cancer? The clinical results from several trials suggest ...
Provided by PR NewswireSep 24, 2025, 11:00:00 AM Marengo to Present a Late-breaking Clinical Oral Abstract at ESMO 2025 on Initial Phase 2 Clinical Data of Invikafusp Monotherapy Activity in Patients ...
Induction Yervoy (ipilimumab) plus Opdivo (nivolumab) followed by consolidative chemoradiotherapy demonstrated bladder ...
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results